COMMENTARY: BRCA1/2 Mutations, Vulnerability to Breast/Ovarian Cancer, and Current and Future Treatment Modalities. (2016). Journal of Cancer Research Updates, 5(2),  45-46. https://doi.org/10.6000/1929-2279.2016.05.02.1